103 results
8-K
EX-99.1
CRVO
CervoMed Inc
5 Apr 24
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
4:06pm
A warrant to purchase one share of common stock to a select group of institutional and accredited healthcare specialist investors led by RA Capital
8-K
EX-10.1
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
representatives as of the day and year first above written.
PURCHASER:
RA CAPITAL HEALTHCARE FUND, L.P.
By:
RA Capital Healthcare Fund GP, LLC
Its:
General …
Number of
Pre-
Funded
Warrants
Number of
Series A
Warrants
Aggregate Purchase
Price of Securities
RA Capital Healthcare Fund, L.P.
Armistice Capital
8-K
EX-99.1
CRVO
CervoMed Inc
28 Mar 24
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
8:36am
Exhibit 99.1
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
Funding from new investors … and accredited healthcare specialist investors in a private placement. A Unit comprised of one share of common stock and one Series A warrant shall have a purchase
8-K
EX-99.1
ywuceqg
7 Feb 24
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
4:06pm
8-K/A
EX-99.3
stwjjsk2iwe5
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K/A
EX-99.2
urazuuug ujf2nkge
29 Sep 23
Completion of Acquisition or Disposition of Assets
4:01pm
8-K
2v7ag
17 Aug 23
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
4:15pm
424B3
23go075uu
13 Jul 23
Prospectus supplement
4:32pm
S-4/A
si54js4wv
22 Jun 23
Registration of securities issued in business combination transactions (amended)
9:46pm
S-4
sau krh1dv8vwl
10 May 23
Registration of securities issued in business combination transactions
9:56pm
PRRN14A
jo2if oa6
6 Dec 22
Revised preliminary proxy statement filed by non-management
8:30am
DEFA14A
EX-99.1
qkuw3 v1d
5 Dec 22
Additional proxy soliciting materials
9:59pm
8-K
EX-99.1
fbwhqh
5 Dec 22
Diffusion has a highly engaged and independent board that possesses the right skills and experience to execute the strategic review process
9:58pm
DEFC14A
219fx02iszv48
5 Dec 22
Proxy in contested solicitation
5:12pm